VISmodegib for ORbital and Periocular Basal Cell Carcinoma
Clinical trial NCT02436408 · COMPLETED
Trial details
- NCT number
- NCT02436408
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-15
- Primary completion
- 2020-09-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.